S2 Genomics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

S2 Genomics General Information

Description

Developer of a spatial sequencing technology designed to provide products that process raw tissues into samples ready for genomic analyses. The company's technology automates the preparation of single cells or nuclei suspensions from solid tissue samples, which permits researchers to isolate rapidly and reproducibly and minimal impact on the cellular transcriptome, enabling clinicians to optimize both the quantity and quality of viable cells or nuclei isolated from a variety of tissue types.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 6712 Preston Avenue
  • Suite D
  • Livermore, CA 94551
  • United States
+1 (925)
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Other Healthcare Technology Systems
Parent Company
Vertical(s)
Corporate Office
  • 6712 Preston Avenue
  • Suite D
  • Livermore, CA 94551
  • United States
+1 (925)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

S2 Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 17-Sep-2025 Completed Generating Revenue
6. Later Stage VC (Series A) 23-Jan-2024 Completed Generating Revenue
5. Debt - General 01-Jan-2022 Completed Generating Revenue
4. Angel (individual) 06-Jul-2021 Completed Generating Revenue
3. Seed Round 11-Dec-2019 Completed Generating Revenue
2. Grant 26-Jun-2018 $280K Completed Generating Revenue
1. Grant 13-Jun-2018 $20.6M Completed Generating Revenue
To view S2 Genomics’s complete valuation and funding history, request access »

S2 Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view S2 Genomics’s complete cap table history, request access »

S2 Genomics Patents

S2 Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025179189-A1 System and method for tissue analysis Pending 21-Feb-2024
WO-2024073453-A2 Tissue processing cartridge and instrument Inactive 26-Sep-2022
WO-2024073453-A3 Tissue processing cartridge and instrument Inactive 26-Sep-2022
EP-4487100-A2 Method and apparatus for processing tissue samples Pending 02-Mar-2022
EP-4487100-A4 Method and apparatus for processing tissue samples Pending 02-Mar-2022 C12N15/1065
To view S2 Genomics’s complete patent history, request access »

S2 Genomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

S2 Genomics Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
BroadOak Capital Partners Growth/Expansion Minority
Cambrian Growth Partners Growth/Expansion Minority
GCAIA Capital Angel Group
HealthTech Capital Angel Group Minority
Life Science Angels Angel Group Minority
You’re viewing 5 of 13 investors. Get the full list »

S2 Genomics FAQs

  • When was S2 Genomics founded?

    S2 Genomics was founded in 2016.

  • Where is S2 Genomics headquartered?

    S2 Genomics is headquartered in Livermore, CA.

  • What is the size of S2 Genomics?

    S2 Genomics has 19 total employees.

  • What industry is S2 Genomics in?

    S2 Genomics’s primary industry is Other Devices and Supplies.

  • Is S2 Genomics a private or public company?

    S2 Genomics is a Private company.

  • What is S2 Genomics’s current revenue?

    The current revenue for S2 Genomics is .

  • How much funding has S2 Genomics raised over time?

    S2 Genomics has raised $18.4M.

  • Who are S2 Genomics’s investors?

    BroadOak Capital Partners, Cambrian Growth Partners, GCAIA Capital, HealthTech Capital, and Life Science Angels are 5 of 13 investors who have invested in S2 Genomics.

  • When was S2 Genomics acquired?

    S2 Genomics was acquired on 17-Sep-2025.

  • Who acquired S2 Genomics?

    S2 Genomics was acquired by Precision Cell Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process